Advaxis Earnings Perspective: Return On Capital Employed
According to data from Benzinga Pro, during Q3, Advaxis's (NASDAQ:ADXS) reported sales totaled $250.00 thousand. Despite a 34.65% increase in earnings, the company posted a loss of $4.13 million.
Advaxis Q3 EPS $(0.02) Beats $(0.04) Estimate, Sales $250.00K
Advaxis (NASDAQ:ADXS) reported quarterly losses of $(0.02) per share which beat the analyst consensus estimate of $(0.04) by 50 percent. This is a 77.78 percent increase over losses of $(0.09) per share from the same
53 Biggest Movers From Friday
Gainers
Innate Pharma S.A. (NASDAQ: IPHA) shares surged 47.1% to settle at $6.15 on Friday after SVB Leerink upgraded the stock from Market Perform to Outperform.
20 Stocks Moving in Friday’s Pre-Market Session
Gainers
Cellect Biotechnology Ltd. (NASDAQ: APOP) rose 59.5% to $8.77 in pre-market trading after the company announced the ApoGraft bone marrow transplantation of the first patient in the US.
63 Biggest Movers From Yesterday
Gainers
Support.com, Inc. (NASDAQ: SPRT) shares surged 41.1% to settle at $19.70 on Thursday on abnormally high volume.
45 Stocks Moving In Thursday’s Mid-Day Session
Gainers
Blue Water Acquisition Corp. (NASDAQ: BLUW) shares climbed 57% to $16.41. Blue Water Acquisition is expected to hold a special meeting of its stockholders on Friday, August 27, 2021.
